109 related articles for article (PubMed ID: 35587058)
1. MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2.
Sun B; Zhao J; Shao ZY
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3083-3090. PubMed ID: 35587058
[TBL] [Abstract][Full Text] [Related]
2. LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203.
Luo T; Yan L; Liu H
J BUON; 2020; 25(3):1517-1524. PubMed ID: 32862599
[TBL] [Abstract][Full Text] [Related]
3. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9.
Kong YJ; Tan XX; Zhang Y; He QJ; Zhao L; Meng Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10370-10378. PubMed ID: 31841191
[TBL] [Abstract][Full Text] [Related]
4. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
5. MiR-1226, mediated by ASCL1, suppresses the progression of non-small cell lung cancer by targeting FGF2.
Lin F; Li R
Bull Cancer; 2022 Apr; 109(4):424-435. PubMed ID: 35164915
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer.
Ma Z; Wei K; Yang F; Guo Z; Pan C; He Y; Wang J; Li Z; Chen L; Chen Y; Xia Y
Cell Death Dis; 2021 Sep; 12(9):840. PubMed ID: 34497265
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
[TBL] [Abstract][Full Text] [Related]
9. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
10. MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression.
Li XJ; Chen LW; Gao P; Jia YJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12741-12747. PubMed ID: 33378022
[TBL] [Abstract][Full Text] [Related]
11. MiR-889 promotes cell growth in human non-small cell lung cancer by regulating KLF9.
Han X; Tang Y; Dai Y; Hu S; Zhou J; Liu X; Zhu J; Wu Y
Gene; 2019 May; 699():94-101. PubMed ID: 30849540
[TBL] [Abstract][Full Text] [Related]
12. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.
Qi Y; Zha W; Zhang W
J BUON; 2019; 24(2):599-607. PubMed ID: 31128012
[TBL] [Abstract][Full Text] [Related]
15. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
16. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.
Chen X; Wang K
Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021
[TBL] [Abstract][Full Text] [Related]
17. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11.
Sun B; Hua J; Cui H; Liu H; Zhang K; Zhou H
Biomed Pharmacother; 2019 Sep; 117():109041. PubMed ID: 31181445
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
Ren P; Gong F; Zhang Y; Jiang J; Zhang H
Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
